Envoy Medical Inc. has announced the grant of its 40th active U.S. patent, further strengthening its intellectual property portfolio. The company also holds 45 issued foreign patents. The newly granted U.S. Patent No. 12,485,288 covers proprietary cochlear implant systems designed to enhance performance and reliability, enabling real-time measurement and adjustment of electrical current delivered from the implant's stimulator to the auditory nerve.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 276539) on December 02, 2025, and is solely responsible for the information contained therein.